A new treatment for asthma and COPD attacks could revolutionise patient care, scientists say. An injection given during ...

Argenx’s investigational therapy, subcutaneous efgartigimod alfa, has been granted Promising Innovative Medicine (PIM) status ...

Process efficiencies – QR codes provide a continuous gateway to the latest PI, reducing the time spent to produce and approve ...

How the UK medical cannabis market is tackling supply chain strain ...

Imagine cruising down a highway, with the hum of the engine and road beneath you, travelling towards your destination. On the ...

We are on the cusp of a new era. With net zero hurtling up the agenda, our industry must view decarbonisation as a wider ...

Whenever the subject of elections comes up on news programmes, and in the last few months it has come up quite a lot, few ...

PharmaTimes Marketer of the Year Awards and Communications Awards ...